|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0007137,
umls-concept:C0015230,
umls-concept:C0030705,
umls-concept:C0034561,
umls-concept:C0087111,
umls-concept:C0162791,
umls-concept:C0376298,
umls-concept:C0460004,
umls-concept:C1273870,
umls-concept:C1522449,
umls-concept:C2916831
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-12-31
|
|
pubmed:abstractText |
Radiation dermatitis occurs to some degree in most patients receiving radiotherapy, with or without chemotherapy. Patients with squamous cell carcinoma of the head and neck (SCCHN) who receive radiotherapy in combination with epidermal growth factor receptor (EGFR) inhibitors, such as cetuximab, may develop a characteristic acne-like rash in addition to dermatitis. Design: An advisory board of 11 experienced radiation oncologists, medical oncologists and dermatologists discussed the management options for skin reactions in patients receiving EGFR inhibitors and radiotherapy for SCCHN. Skin toxicity was categorised according to the National Cancer Institute-Common Terminology Criteria for Adverse Events (version 3) grading.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
pubmed-author:AngK KKK,
pubmed-author:BensadounR-JRJ,
pubmed-author:BernierJJ,
pubmed-author:BonnerJJ,
pubmed-author:DummerRR,
pubmed-author:GiraltJJ,
pubmed-author:HartleyAA,
pubmed-author:KornekGG,
pubmed-author:MesiaRR,
pubmed-author:RobertCC,
pubmed-author:SegaertSS,
pubmed-author:VermorkenJ BJB
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
142-9
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17785763-Acneiform Eruptions,
pubmed-meshheading:17785763-Anti-Inflammatory Agents,
pubmed-meshheading:17785763-Antibiotic Prophylaxis,
pubmed-meshheading:17785763-Antibodies, Monoclonal,
pubmed-meshheading:17785763-Carcinoma, Squamous Cell,
pubmed-meshheading:17785763-Combined Modality Therapy,
pubmed-meshheading:17785763-Disease Management,
pubmed-meshheading:17785763-Head and Neck Neoplasms,
pubmed-meshheading:17785763-Humans,
pubmed-meshheading:17785763-Neoplasm Proteins,
pubmed-meshheading:17785763-Protein Kinase Inhibitors,
pubmed-meshheading:17785763-Radiodermatitis,
pubmed-meshheading:17785763-Radiotherapy,
pubmed-meshheading:17785763-Receptor, Epidermal Growth Factor,
pubmed-meshheading:17785763-Severity of Illness Index,
pubmed-meshheading:17785763-Skin Care,
pubmed-meshheading:17785763-Staphylococcal Skin Infections
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Genolier Swiss Medical Network, Genolier, Geneva, Switzerland. jacques.bernier@hcuge.ch
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Practice Guideline,
Consensus Development Conference
|
